This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
H&R Block (HRB) Banks on Five-Year Strategy Amid High Debt
by Zacks Equity Research
Solid shareholder-friendly measures boost H&R Block (HRB). However, high debt is worrisome.
Trane Technologies' (TT) Growth Initiatives Impress, Debt Ails
by Zacks Equity Research
Trane Technologies (TT) continues to focus on steps to increase revenue stream from parts, services, controls, used equipment and rentals.
Can Cross Country (CCRN) Climb 25% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Cross Country (CCRN) points to a 25.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
5 Stocks to Add to Your Portfolio Post Broker Upgrade
by Maharathi Basu
Broker-friendly stocks like ArcBest (ARCB), Atlas Air (AAWW), Cross Country Healthcare (CCRN), Asbury Automotive (ABG) and Avnet (AVT) should grace one's portfolio.
Cross Country Healthcare (CCRN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $21.83 in the latest trading session, marking a +0.46% move from the prior day.
Cross Country Healthcare (CCRN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $22.41 in the latest trading session, marking a +0.04% move from the prior day.
Broadridge (BR) Rides on Recurring Revenues, Debt Woes Persist
by Zacks Equity Research
Broadridge (BR) has a robust business model that ensures significant recurring-fee revenues. A debt-laden balance sheet is concerning.
Zacks.com featured highlights include: Atlas Air Worldwide Holdings, ArcBest Corp., Archer Daniels, Cross Country Healthcare and Asbury Automotive Group
by Zacks Equity Research
Atlas Air Worldwide Holdings, ArcBest Corp., Archer Daniels, Cross Country Healthcare and Asbury Automotive Group are highlighted in this Screen of the Week article.
5 Stocks to Buy Following Recent Upgrade by Brokers
by Maharathi Basu
Investors should add broker-friendly stocks like ArcBest (ARCB), Archer Daniels (ADM), Atlas Air (AAWW), Cross Country Healthcare (CCRN) and Asbury Automotive (ABG) to their respective portfolios for handsome returns.
Cross Country Healthcare (CCRN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $22.16 in the latest trading session, marking a +0.82% move from the prior day.
Why the Earnings Surprise Streak Could Continue for Cross Country (CCRN)
by Zacks Equity Research
Cross Country (CCRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FTI Consulting (FCN) Appoints Senior MD for M&A and Activism
by Zacks Equity Research
FTI Consulting (FCN) welcomes Patrick Tucker to the position of senior managing director in its Mergers & Acquisitions and Activism practice within the Strategic Communications segment in New York.
Cross Country Healthcare (CCRN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Cross Country Healthcare (CCRN) closed at $17.92, marking a -0.22% move from the previous day.
ICF International (ICFI) Appoints New Chief Financial Officer
by Zacks Equity Research
ICF International (ICFI) welcomes Barry Broadus to the position of chief financial officer.
Here's Why Cross Country (CCRN) is Poised for a Turnaround After Losing 35.9% in 4 Weeks
by Zacks Equity Research
Cross Country (CCRN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
5 Reasons Why FactSet (FDS) Stock Might be a Great Pick Now
by Zacks Equity Research
FactSet (FDS) looks strong on the back of higher organic revenues, increase in annual subscription value, strong global network and innovative portfolio.
Charles River (CRAI) Stock Up 44% in a Year: Here's Why
by Zacks Equity Research
Consecutive better-than-expected top- and bottom-line performances, and shareholder-friendly moves has been aiding Charles River (CRAI) stock.
IHS Markit's (INFO) Q4 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
IHS Markit's (INFO) fourth-quarter fiscal 2021 earnings and revenues increase year over year.
Here's Why You Should Consider Core & Main (CNM) Stock Now
by Zacks Equity Research
Core & Main (CNM) is benefiting from solid demand across each of its end markets.
5 Reasons Why You Should Invest in Clean Harbors (CLH) Stock
by Zacks Equity Research
Strategic capital investments with improved business efficiency, diversified service offerings and buyouts should drive Clean Harbors' (CLH) prospects.
Reasons to Hold on to Montrose Environmental (MEG) Stock
by Zacks Equity Research
Montrose Environmental Group (MEG) is benefiting from robust organic growth across service lines.
Reasons to Retain Robert Half (RHI) Stock in Your Portfolio
by Zacks Equity Research
Robert Half (RHI) has been utilizing a major share of its capital expenditures on investments in software initiatives and technology infrastructure.
Aptiv (APTV) to Gain From Wind River Acquisition: Here's How
by Zacks Equity Research
The latest deal is expected to enhance Aptiv's (APTV) Advanced Safety & User Experience segment.
Here's Why You Should Hold on to Green Dot (GDOT) Stock
by Zacks Equity Research
Green Dot's (GDOT) long-standing relationship with Walmart remains a key driver of its operating revenues.
6 Reasons to Bet on Automatic Data Processing (ADP) Stock
by Zacks Equity Research
The recent acquisition of Integrated Design is expected to expand the reach of Automatic Data Processing's (ADP) comprehensive HCM and Workforce Management solutions.